|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K 39/39 | (2006.01) |
| (11) | Number of the document | 3106176 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16183076.5 |
| Date of filing the European patent application | 2012-12-06 | |
| (97) | Date of publication of the European application | 2016-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-11 |
| (46) | Date of publication of the claims translation | 2018-01-10 |
| (30) | Number | Date | Country code |
| 11192230 | 2011-12-06 | EP | |
| PCT/EP2012/0543 | 2012-03-13 | WO |
| (72) |
Möhlen, Michael, AT
Weber, Michael, AT
Wruss, Jürgen, AT
Schlegl, Robert, AT
|
| (73) |
Valneva Austria GmbH,
Campus Vienna Biocenter 3, 1030 Vienna,
AT
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Aliuminio junginiai, skirti naudoti terapijoje ir vakcinose |
| ALUMINIUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES |
| Payment date | Validity (years) | Amount | |
| 2021-11-24 | 10 | 231.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-03-20 |